X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drug prices PhRMA earned a major win against legislation that would have stopped drugmakers from denying generic-drug companies the ability to study their products to bring low-cost competition to market. (Photo: Shutterstock)

The drug industry set several quarterly records for lobbying spending in the first three months gof 2018 as it faced pressure from President Donald Trump’s administration and lawmakers on drug pricing, generic medicines and trade.

BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.